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OBJECTIVE—Estradiol (E2) is known to modulate insulin
sensitivity and, consequently, glucose homeostasis. Resveratrol
(RSV), an agonist of estrogen receptor (ER), has exerted antihy-
perglycemic effects in streptozotocin-induced type 1 diabetic rats
in our previous study and was also shown to improve insulin
resistance in other reports. However, it remains unknown
whether activation of ER is involved in the metabolic effects of
RSV via insulin-dependent and -independent mechanisms.
RESEARCH DESIGN AND METHODS—Male Sprague-Daw-
ley rats were given a high cholesterol–fructose (HCF) diet for 15
weeks and were treated with RSV for either 15 days or 15 weeks.
RESULTS—Here, we show that RSV shifts the metabolic char-
acteristics of rats on an HCF diet toward those of rats on a
standard diet. RSV treatment increased insulin-stimulated whole-
body glucose uptake and steady-state glucose uptake of soleus
muscle and liver in HCF-fed rats as well as enhanced membrane
trafﬁcking activity of GLUT4 and increased phosphorylation of
insulin receptor in insulin-resistant soleus muscles. Interestingly,
the phosphorylated ER level in insulin-resistant soleus muscle
was signiﬁcantly elevated in rats with RSV treatment in both
basal and euglycemic-hyperinsulinemic conditions. RSV exerted
an insulin-like stimulatory effect on isolated soleus muscle,
epididymal fat and hepatic tissue, and C2C12 myotubes. The
RSV-stimulated glucose uptake in C2C12 myotubes was depen-
dent on extracellular signal–related kinase/p38 (early phase, 1 h)
and p38/phosphoinositide 3-kinase (late phase, 14 h) activation.
Inhibition of ER abrogated RSV-induced glucose uptake in both
early and late phases.
CONCLUSIONS—Collectively, these results indicate that ER is
a key regulator in RSV-stimulating insulin-dependent and -inde-
pendent glucose uptake, which might account for the protective
effects of RSV on diet-induced insulin resistance syndrome.
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R
ecent investigations have revealed a pivotal role
for estradiol (E2) in regulating energy metabo-
lism and have opened new insights into the
physiological role of estrogen receptors (ERs)
(1,2). Mice that lack ER- resulted in insulin resistance,
impaired glucose tolerance, adipocyte hyperplasia, and
hypertrophy. Both males and females exhibited these
features, highlighting the importance of the E2–ER action
for the maintenance of glucose homeostasis (3). Phytoa-
lexin resveratrol (RSV) (3,4,5-trihydroxy-trans-stilbene)
has structural similarities to the synthetic estrogen dieth-
ylstilbestrol. It has been shown to bind to and activate
gene transcription via the ER in estrogen-sensitive tissues
and cell lines (4,5). In addition, it has been revealed that
ER- is a positive regulator of GLUT4 expressions,
whereas ER- has a suppressive role (6,7). A previous
study (8) has demonstrated that RSV binds ER- with
lower afﬁnity than ER-. Therefore, the present study was
focused on the involvement of ER- instead of ER-
activation in RSV action.
Furthermore, the potential therapeutic effects of RSV
have been revised intensely in recent years. RSV has been
documented to possess a cardioprotective effect, a chemo-
protective agent in cancer therapy, and an activator of
sirtuin deacetylases, which is related to the extension of
lifespan (9–11). More recently, RSV treatment has been
reported to protect mice against diet-induced obesity and
insulin resistance (12,13). On the other hand, our previous
study (14) showed that RSV exerted an antihyperglycemic
effect in streptozotocin-induced type 1 diabetic rats. Taken
together, it is suspected that the activation of the ER
signaling pathway might also play a crucial role in the
beneﬁcial effects of RSV on insulin resistance syndrome.
Components of the diet related to the changes in eating
habits that characterize the modern Western world are
important factors in the increasingly high prevalence of
chronic diseases, including obesity, diabetes, and hyper-
tension. To mimic Western eating habits characterized by
consuming a high-cholesterol diet combined with sugar-
sweetened beverages, we fed rats with a high-cholesterol
diet combination with 10% fructose in drinking water
(HCF diet) for 15 weeks and found that these rats could
develop a phenotype of insulin resistance syndrome char-
acterized by an increase in blood pressure, hyperlipidemia,
hyperinsulinemia, and impaired glucose tolerance with
relative normal body weight gain, as previously described
(15). Since the beneﬁcial effects of RSV on obesity and
insulin resistance were functionally intertwined in an
obesity-induced insulin-resistant animal model (12,13),
HCF diet–fed rats instead of obese rats were chosen in the
present study to test whether ER signaling is directly
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and muscular insulin resistance without the potential
disturbance of RSV-mediated anti-obese effect to data
interpretation. Our ﬁndings suggest that the RSV-activated
ER signaling pathway is crucial for its stimulating effects
on muscular glucose uptake, which might account for at
least in part the beneﬁcial effect of RSV on HCF diet–
induced insulin resistance syndrome. It implicates a ther-
apeutic potential of RSV in the treatment of patients, in
particular menopausal women with type 2 diabetes.
RESEARCH DESIGN AND METHODS
Animals and diets. Male Sprague-Dawley rats were purchased from the
National Laboratory Animal Breeding and Research Center (Taipei, Taiwan).
The rats were housed in an animal room with a constant temperature of 22 
1°C and a ﬁxed 12-h light/dark cycle. All animals were handled and housed
according to the guidelines and manual of the committee of the care of
laboratory animals of Chang Gung University.
Rats weighing 150–170 g were randomly assigned to four groups fed
regular standard diet (5.1% fat, 23.5% protein, and 50.3% carbohydrate, LabDiet
5010) (control, n  30) or a high-cholesterol diet (4% cholesterol, 10.1% fat,
17% protein, and 51.6% carbohydrate, TD03468; Harlan Teklad, Indianapolis,
IN) with 10% fructose in drinking water (n  58) for 15 weeks. Then, the HCF
diet–fed rats were further divided into three subgroups concomitantly treated
with vehicle (HCF diet group, n  28), RSV for 15 days (HCF  RSV 15D
group, n  15), or RSV for 15 weeks (HCF  RSV 15W group, n  15).
Resveratrol (1 mg  kg
1  day
1) was suspended in a 0.9% saline solution and
administered by oral gavage once a day for 15 days or 15 weeks. Body weight,
water, and food intake were recorded weekly. A separate set of rats (n  8 per
group) were killed with an overdose of pentobarbital (100 mg/kg i.p.) at the
end of basal and euglycemic-hyperinsulinemic clamp periods to measure the
GLUT4 translocation and phosphorylation of insulin resistance and ERs in
soleus muscle.
Euglycemic-hyperinsulinemic clamp experiment with tracer dilution
method. A euglycemic-hyperinsulinemic clamp technique with tracer dilution
method was performed, as previously described (16–20). The detailed proce-
dures are described in the online appendix (available at http://dx.doi.org/
10.2337/db07-1750).
Immunoblotting. To assess GLUT4 and GLUT1 distribution between the
intracellular membranes and the plasma membranes, rat soleus muscle and
C2C12 skeletal muscle cells (ATCC, Manassas, VA) were subjected to subcel-
lular membrane fractionation, as recently described (21). In brief, tissues were
ﬁrst homogenized in a lysis buffer (50 mmol/l Tris, pH 7.4; 50 mmol/l
glycerophosphate; 20 mmol/l NaF; 2 mmol/l EDTA; 2 mmol/l Na3VO4; 250
mmol/l sucrose; and 1% -mercaptoethanol) with 1 mmol/l phenylmethylsul-
fonylﬂuoride as a protease inhibitor. A sample of the crude homogenate was
saved for protein determination, and the remainder was centrifuged (15,000g).
The supernatant was then further centrifuged at 44,000g, the pellet discarded,
and the liquid phase pelleted at 200,000g, resulting in an intracellular mem-
brane–enriched fraction. For plasma membrane enrichment, the 15,000g
pellet was dissolved in a buffer containing 1% Triton 100 and centrifuged at
200g. Fractions enriched in intracellular membrane and plasma membrane
were dissolved in sucrose buffer and stored at 70°C. Protein samples of
intracellular membranes, plasma membranes, and total lysates were subjected
to 10% SDS-PAGE and electrophoretically transferred to polyvinylidene
ﬂuoride membrane for 2 h. The membrane was blocked in 5% nonfat milk in
Tris-buffered saline with 0.1% Tween 20. It was then washed and blotted with
anti-GLUT1, GLUT4 (Chemicon), ER-, p-ER--ser 118, insulin receptor
(InsR), p-InsR--tyr 1146 (Cell Signaling), Akt, p-Akt-thr308, p-Akt-ser 473
(Santa Cruz), p38, p-p38-thr 180/tyr 1146, extracellular signal–related kinase
(Erk), and p-Erk-thr 202/tyr 204 (Chemicon) antibodies. The membrane was
then incubated with horseradish peroxidase–conjugated secondary antibody
before chemiluminescence detection (Pierce).
2-Deoxy-[
3H] glucose uptake in C2C12 myotubes. Mouse C2C12 myoblasts
were maintained in Dulbecco’s modiﬁed Eagle’s medium supplemented with
10% fetal bovine serum at 37°C with 95% air and 5% CO2. To induce
differentiation, cells were switched to Dulbecco’s modiﬁed Eagle’s medium
containing 1% fetal bovine serum for 3 days. For the glucose uptake assay,
cells were cultured on 12-well cluster dishes, washed twice with PBS and
incubated in serum-free media for 16 h and then treated with or without
insulin (0.792 mol/l) or RSV (0.1 mol/l) in Dulbecco’s modiﬁed Eagle’s
medium for 1 or 14 h at 37°C. After treating with the agonist, uptake of
2-deoxy-[
3H] glucose (0.24 mol/l) was measured over 10 min. Reactions were
terminated by the removal of the permanent solution and rapid washing with
ice-cold 20 mmol/l phloretin, a speciﬁc inhibitor of equilibrative glucose
transport. Cells were then dissolved in 0.1 N KOH, and aliquots were counted
by liquid scintillation counting or were used to determine protein concentra-
tion. In some experiments, cells were preincubated with wortmannin or
Ly294002 (100 nmol/l, inhibitors of phosphatidylinositol 3-kinase [PI3K]),
PD98059 (10 mol/l, an inhibitor of mitogen-activated protein kinase kinase),
SB203580 (10 mol/l, an inhibitor of p38), or ICI 182780 (1 mol/l, an inhibitor
of ER) for 30 min at 37°C before treatment with RSV (0.1 mol/l).
Biochemical analysis. Blood was collected from the tail vein for biochemical
measurements in experimental rats after overnight fasting. Plasma was used
for the measurements of total cholesterol, HDL, triglycerides, and uric acid
(Randox reagent kits; Randox Laboratories, Antrim, U.K.). Insulin was mea-
sured using a commercially available kit provided by Mercodia (rat insulin
enzyme-linked immunosorbent assay kit; Uppsala, Sweden). Blood glucose
samples were determined by the glucose oxidase method (chemistry analyzer,
Auto Analyzer; Quik-Lab, Ames, Spain).
Direct blood pressure measurement. Direct blood pressure measurement
was performed in the experimental rats by connecting the femoral artery
catheter to the Maclab Data Acquisition System (AD Instruments, Castle Hill,
NSW, Australia) through a pressure transducer for arterial pressure and heart
rate monitoring.
Statistical analysis. Data were expressed as means  SE. The difference in
RSV-stimulated 2-deoxy-[
14C]glucose (2-DG) uptake was analyzed by one-way
ANOVA and followed by Bonferroni’s post hoc test. Others were analyzed by
Student’s t test, with the signiﬁcant difference set at P 	 0.05.
RESULTS
RSV protects against HCF diet–induced insulin resis-
tance syndrome in rats. As shown in Table 1, the average
body weight of HCF diet–fed rats was slightly lower than
that of control rats and failed to change after RSV (1 mg 
kg
1  day
1) treatment for 15 days or 15 weeks. There was
no difference in caloric intake between control rats and
TABLE 1
Metabolic characteristics in rats fed with standard diet (control) or with HCF diet for 15 weeks
Control group HCF-diet group HCF  RSV 15D group HCF  RSV 15W group
n 30 28 15 15
Body weight (g) 536  9 470  11 (	0.001)* 470  10 484  13
Caloric intake (kcal  rat
1  day
1) 138  7 135  6 125  10 148  8
Glucose (mg/dl) 89  59 3  59 5  49 2  3
Insulin (mg/l) 0.45  0.03 2.84  0.46 (	0.001)* 1.53  0.18 (	0.05)† 0.62  0.05 (	0.001)†
Cholesterol (mg/dl) 73  5 369  21 (	0.001)* 236  14 (	0.001)† 159  10 (	0.001)†
Triglycerides (mg/dl) 95  4 127  4( 	0.001)* 112  3( 	0.001)† 73  3( 	0.001)†
HDL (mg/dl) 28  12 5  12 7  23 0  1( 	0.05)†
Uric acid (mg/dl) 0.71  0.01 1.08  0.02 (	0.01)* 1.05  0.02 0.83  0.01 (	0.01)†
Mean arterial pressure (mmHg) 106  1 123  2( 	0.01)* 123  1 119  1
Data are means  SE or means  SE (P). The HCF-diet rats were either treated with RSV for 15 days (HCF  RSV 15D) or for 15 weeks
(HCF  RSV 15W). *Versus control; †versus HCF.
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throughout the study. HCF diet feeding for 15 weeks
progressively increased the severity of insulin resistance
syndrome characterized by elevated blood pressure, in-
creased fasting plasma cholesterol, triglycerides, insulin,
and uric acid in a time-dependent manner. However, HCF
diet feeding did not alter fasting plasma glucose and HDL
levels. RSV treatment for 15 days and 15 weeks time-
dependently attenuated the elevated insulin, cholesterol,
and triglyceride levels. In addition, RSV treatment for 15
weeks signiﬁcantly reduced the increased uric acid
levels and conversely increased plasma HDL levels in
HCF diet–fed rats. The RSV treatment for 15 weeks also
slightly lowered mean arterial pressure in HCF diet–fed
rats (difference is not signiﬁcant). These results suggest
that RSV shifts the metabolic characteristics of rats on
the HCF diet toward those of rats on standard diet,
signiﬁcantly alleviating their insulin resistance syn-
drome. Notably, all these changes occurred without the
signiﬁcant changes in body weight and caloric intake
among the groups.
RSV attenuates HCF diet–induced whole-body and
muscular insulin resistance in a euglycemic-hyperin-
sulinemic clamp study. As shown in Fig. 1, under similar
euglycemic and hyperinsulinemic conditions, RSV treat-
ment signiﬁcantly alleviated HCF diet–induced insulin
resistance, as indicated by improving the diminished insu-
lin-mediated stimulatory effect on whole-body glucose
uptake as well as tissue-speciﬁc (soleus muscle; vastus
lateralis red muscle; and liver, but not epididymal, fat;
extensor digitorum longus muscle; and vastus lateralis
white muscle) glucose uptake in HCF diet–fed rats in a
time-dependent manner (Fig. 1 and online appendix Fig.
1S). The improving effect of RSV on insulin-stimulating
muscular glucose uptake (soleus muscle) (Fig. 1) was
concomitant with increases in GLUT4 membrane translo-
cation and InsR phosphorylation (Fig. 2). Notably, RSV
also signiﬁcantly reversed HCF diet–induced decreases in
basal membranous GLUT4 and phosphorylated InsR pro-
tein levels in soleus muscles. These data implicate that
RSV could improve whole-body and muscular glucose
uptake via insulin-dependent and -independent pathways
in HCF diet–induced insulin-resistant rats.
RSV increases ER phosphorylation in vivo and in
vitro. As shown in Fig. 3, under both basal and euglyce-
mic-hyperinsulinemic conditions, RSV treatment markedly
increased ER- protein phosphorylation in HCF diet–
induced insulin-resistant soleus muscles. Taken together
with Fig. 2, these results suggest that both RSV treatments
for 15 days and 15 weeks could signiﬁcantly enhance ER
and InsR activities as well as GLUT4 translocation to the
plasma membrane in HCF diet–induced insulin-resistant
soleus muscles (Fig. 3A). On the other hand, RSV (0.1
mol/l) treatment also signiﬁcantly increased phosphory-
lation of ER- at ser118 during the 2-h observation period
in C2C12 myotubes (Fig. 3B). These in vivo and in vitro
results suggest that RSV might directly elicit ER activation
in skeletal muscles.
RSV directly stimulates glucose uptake in isolated
soleus muscle and C2C12 myotubes. Acute RSV treat-
ment for 30 min could directly stimulate glucose uptake in
isolated rat soleus muscle, epididymal fat pads, and he-
patic tissue in a dose-dependent manner in normal rats, as
shown in online appendix Fig. 2S. To investigate the
underlying mechanism of RSV-stimulating muscular glu-
cose uptake in the model of muscle cell line, the 2-DG
uptake and expression of membranous GLUT4 were mea-
sured in C2C12 myotubes with RSV treatment. We ﬁrst
examined the dose- and time-dependent effects of RSV on
glucose uptake in C2C12 myotubes. The maximal effective
dose of RSV-stimulated glucose uptake was between 0.1
and 0.3 mol/l, which is close to those in isolated rat
soleus muscle. RSV-stimulated glucose uptake reached a
peak level at the 1-h mark (ﬁrst wave), and then the second
phase of activation was observed in 14 h. RSV also directly
induced glucose uptake and stimulated GLUT4 transloca-
tion to the plasma membrane in a dose-dependent manner
in C2C12 myotubes (online appendix Fig. 3S).
RSV stimulates glucose uptake in C2C12 myotubes in
an ER-dependent manner. To further elucidate the role
and characteristic of ER-mediated signaling pathway in
RSV-induced glucose uptake and GLUT4 membrane trans-
location, we compared the effect of RSV with or without
insulin, ER agonist (estradiol, E2), and ER antagonist (ICI
182780) on glucose uptake of C2C12 myotubes. Both RSV
treatments for 1 and 14 h exerted synergistic effect with
insulin but not with E2 on glucose uptake and GLUT4
membrane translocation (Fig. 4A and B). Notably, the
synergistic effect of RSV with insulin was blunted after
longer (14 h) RSV treatment. RSV-induced glucose uptake
and GLUT4 membrane translocation for 1 and 14 h were
both suppressed by ER blocker (Fig. 4C and D). As shown
in Fig. 3B, the level of ER phosphorylation, but not total
ER protein expression, was increased in a two-wave
pattern after RSV administration. These results further
support that RSV and E2 are via the same signaling
pathway to enhance muscular glucose uptake. Moreover,
the result in online appendix Fig. 4S showed that tamox-
ifen, another ER blocker, signiﬁcantly antagonized RSV-
induced glucose uptake (from 129.1  9.53% to 107.2 
3.94%, P 	 0.05) consistent with those with ICI 182780
cotreatment. Collectively, these results indicate that ER is
a key mediator in acute and slow actions of RSV-stimu-
lated GLUT4 membrane translocation and glucose uptake
in C2C12 myotubes.
The signaling pathways involved in RSV-induced mus-
cular glucose uptake. To probe the potential ER and
InsR-mediated signaling pathways involved in RSV-in-
duced muscular glucose uptake, C2C12 myotubes were
treated with RSV and probed with phosphorylation-spe-
ciﬁc antibodies. As shown in Fig. 5, RSV treatment signif-
icantly increased phosphorylation of p38 at thr180 and
tyr1146, Erk at thr202 and tyr204, Akt at thr308 and ser473,
and InsR at tyr1146 in a time-dependent manner. The
ER-, p38, and Erk phosphorylation was started at 5 min in
response to RSV (Figs. 3B and 5A and B). Subsequently,
InsR, Akt (thr 308), and Akt (ser 473) were phosphorylated
at 10, 20, and 30 min, respectively (Fig. 5A and B).
Because both RSV treatments for 1 and 14 h have shown
to enhance glucose uptake and GLUT4 translocation to the
plasma membrane in C2C12 myotubes (as shown in Fig. 4
and online appendix Fig. 3S), we were interested to further
test whether there are different underlying mechanisms
beneath the early- and late-phase actions of RSV in this
part of study. As shown in Fig. 6A, cotreatment with MEK
and p38 inhibitors (PD 98059 and SB 203580), but not PI3K
inhibitor (wortmannin and Ly 294002), completely blocked
the early-phase effect (1 h) of RSV-stimulating glucose
uptake and GLUT4 membrane translocation. Inhibition of
p38 and PI3K, but not Erk, blunted the late-phase effect (14
h) of RSV-induced glucose uptake and GLUT4 membrane
translocation. These results suggest that the signaling
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shifted Erk/p38 activation in the early phase to p38/PI3K
activation in the late phase. Moreover, RSV-evoked phos-
phorylation of p38, Erk, and InsR protein was markedly
suppressed by adding ICI 182780 (ER blocker) (Fig. 6B–
D), indicating that the phosphorylation of p38, Erk, InsR,
and Akt is downstream of RSV-activating ER-–mediated
signaling pathway.
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tet-
razdium bromide assay was used to evaluate mitochondria
activity and cell survival rate in C2C12 myotubes. The
results show that mitochondria activity and cell survival
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FIG. 1. RSV improved whole-body glucose uptake and insulin-stimulated steady-state glucose uptake in HCF diet–induced insulin-resistant rats.
Hepatic glucose production (A), whole-body glucose uptake (B), and tissue-speciﬁc glucose uptake (C–F) under hyperinsulinemic-euglycemic
conditions were performed in control, HCF diet–fed, HCF  RSV 15D, and HCF  RSV 15W rats. Soleus muscle (C), extensor digitorum longus
muscle (D), epididymal fat pad (E), and liver (F) were harvested after 30 min of intravenous injection of 2-DG. Values of 2-DG uptake were
adjusted by the tissues protein content (g). Graph shows the means  SE of eight independent experiments (*Versus control; †versus HCF group;
n  8 per group). , Control (rats fed with standard diet for 15 weeks); f, HCF (rats fed with HCF for 15 weeks); o, HCF  RSV 15D (HCF-fed
rats treated with RSV for 15 days); s, HCF  RSV 15W (HCF-fed rats treated with RSV for 15 weeks). Resveratrol (1 mg  kg
1  day
1) was
suspended in 0.9% saline solution and administered by oral gavage once a day for 15 days or 15 weeks.
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DIABETES, VOL. 57, JULY 2008 1817rate were not affected by inhibitors (SB 203580, PD 98059,
Ly 294002, wortmannin, and ICI 182780) treated alone or in
combination treated with RSV in C2C12 myotubes (data
not shown). In addition, the glucose uptake activity and
GLUT4 translocation to the plasma membrane were not
signiﬁcantly changed in those treated with inhibitors alone
(Fig. 6A).
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tive GLUT1, GLUT4, p-InsR (tyr 1146), and InsR antibodies. All blots
from PM were stripped and reprobed with an antibody for Na
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
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1  day
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control; f, HCF; o, HCF  RSV 15D; s, HCF  RSV 15W.
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FIG. 3. RSV directly increased ER phosphorylation in vivo (soleus
muscles, n  3 per group) and in vitro (C2C12 myotubes, n  3). A:I n
RSV (1 mg/kg)-treated HCF diet–fed rats, phosphorylated ER, but not
protein expression, was signiﬁcantly increased in the conditions with
and without euglycemic-hyperinsulinemic clamp (EHC) as compared
with HCF diet–fed rats. However, the ER phosphorylation was not
enhanced by insulin challenge among the groups (, control; f, HCF;
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control; †versus HCF group). In vitro studies, representative images,
and densitometries from three independent experiments are shown
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estrogen receptor is essential for RSV-evoked p38, Erk,
Akt, and InsR phosphorylation and that inhibition of ER is
sufﬁcient to abrogate RSV-induced GLUT4 membrane
translocation and, consequently, glucose uptake in skele-
tal muscles via insulin-dependent and -independent signal-
ing pathways (Fig. 7).
DISCUSSION
Recent studies (22,23) have indicated that E2 via ER-–
and ER-–mediated signaling pathways participate in glu-
cose homeostasis by modulating the expression of genes
involved in insulin sensitivity and glucose uptake. RSV has
higher afﬁnity to ER-, a positive regulator of GLUT4
expression, than ER-, a suppressive role in skeletal
muscle (6–8). Here, we showed that RSV stimulated
muscular glucose uptake in HCF diet–fed rats (soleus
muscle, vastus lateralis red muscle), isolated soleus mus-
cle, and C2C12 myotubes. Acute RSV administration di-
rectly increased glucose uptake not only in isolated soleus
muscle but also in isolated epididymal fat and hepatic
tissue. RSV could go through eliciting ER- and InsR
phosphorylation, stimulating GLUT4 translocation to
plasma membrane, and consequently increasing muscular
glucose uptake in HCF diet–fed rats and C2C12 myotubes.
Inhibition of ER activation could markedly suppress RSV-
stimulated glucose uptake via p38/Erk (early phase)- and
p38/Akt (late phase)-dependent pathways. Our results
have demonstrated that activation of ER is crucial for the
RSV-evoked insulin-dependent and -independent signaling
pathway (i.e., p38, Erk, Akt, and InsR phosphorylation in a
time-dependent manner).
The present study shows that RSV treatment signiﬁ-
cantly attenuated HCF diet–induced insulin resistance
indicated by reducing fasting hyperinsulinemia and also
whole-body glucose uptake during euglycemic-hyperinsu-
linemic clamp. In addition, RSV administration can induce
InsR phosphorylation and GLUT4 translocation to the
plasma membrane under both basal and euglycemic-hy-
perinsulinemic conditions, indicating that RSV may pos-
sess both insulin-like action and the improving effect on
HCF diet–induced insulin resistance in rats. Furthermore,
RSV has been shown to directly stimulate tissue glucose
uptake in major insulin-sensitive tissues, such as soleus
muscle, epididymal fat, and hepatic tissues. This could
support that RSV possesses insulin-like effect on glucose
uptake of insulin-sensitive tissues. In support of the
present observation, our previous study (14) also demon-
strated that RSV exerted antihyperglycemic effects with-
out altering the plasma insulin levels in streptozotocin-
induced type 1 diabetic rats, suggesting that the metabolic
effect of RSV was not solely due to improved insulin action
on insulin-dependent tissues. On the other hand, the
present results from C2C12 myotubes show that RSV
could stimulate ER-, p38, and Erk phosphorylation at
ﬁrst, followed by InsR and Akt phosphorylation. Moreover,
the synergistic effect of RSV and insulin was diminished
after RSV treatment for a longer period (14 h). This
diminished synergistic effect in parallel with the shift of
RSV-mediated p38/Erk activation to p38/PI3K/Akt activa-
tion also supports that RSV could stimulate muscular
glucose uptake via insulin-independent and -dependent
pathways in a time-dependent manner.
On the other hand, the present results show that RSV
has dominant stimulatory effects on glucose uptake in
slow-twitch muscle ﬁbers (soleus muscle, vastus lateralis
red muscle) than fast-twitch muscle ﬁbers (extensor digi-
torum longus, vastus lateralis white muscle). Soleus and
vastus lateralis (red) muscles are slow-twitch muscle
ﬁbers. The slow-twitch muscle ﬁbers usually account for
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FIG. 4. ER was involved in RSV-stimulated membrane GLUT4 recruit-
ment and glucose uptake in C2C12 myotubes. Plasma membrane (PM)
GLUT4 protein levels (A and C, upper panels) and 2-DG uptake (B and
D, lower panels) were determined after insulin, RSV, estradiol, ICI,
insulin and RSV, estradiol and RSV, or ICI and RSV treatment for 1 h
() and 14 h (f). The results represent the means  SE for ﬁve
independent assays in triplicates (*Versus B, basal control; †versus
RSV, RSV-treated; #versus I, insulin-treated; n  5). B, basal control; I,
insulin (0.792 mol/l, positive control); RSV, RSV (0.1 mol/l); E,
estradiol (0.1 mol/l, ER agonist); ICI, ICI182780 (1 mol/l, ER
inhibitor).
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50% or more total muscle mass in humans and are more
insulin responsive than fast-twitch ﬁbers, implicating the
potential improving effect of RSV on muscular insulin
resistance in humans. In addition, it has been reported that
calcineurin upregulates slow-twitch muscle ﬁber genes in
C2C12 cells (24). Therefore, we think that the mouse
myoblast cell line C2C12 could be an appropriate model
for studying the underlying mechanism of RSV action.
Furthermore, E2 has been considered an important
regulator of glucose homeostasis. ER- and ER- have
been proposed to be the important modulators of GLUT4
expression in skeletal muscle (6,7). The present study
shows that RSV (a phytoestrogen) could directly induce
ER- phosphorylation, but not ER protein expression, in
skeletal muscle both in vivo and in vitro. Inhibition of ER
markedly suppressed RSV-stimulated muscular glucose
uptake, suggesting that the ER activation is crucial for the
RSV-mediated metabolic actions. RSV has been docu-
mented to serve as a SIRT1 (NAD
-dependent deacety-
lase) activator and could affect the regulation of energy
homeostasis via modulation of peroxisome proliferator–
activated receptor- coactivator-1 functions (12,13,25).
Furthermore, RSV has also been reported to have a close
connection with pathways of insulin signaling and lifespan
regulation (26–30). Our observations raise the possibility
that RSV-induced ER activation might be another key
regulator to its stimulating effect on muscular glucose
uptake, independent of its activation of SIRT1 histone
deacetylase.
The male Sprague-Dawley rats were chosen in the
present study to test whether ER signaling is directly
involved in the effects of RSV without the potential distur-
bance of estrogen to data interpretation. In addition,
estradiol via estrogen receptor has been reported to play a
pivotal role in regulation of insulin-mediated glucose me-
tabolism in both males and females (31–33). Therefore,
this study did provide persuasive evidence to implicate the
potential therapeutic effect of RSV on systemic and mus-
cular insulin resistance in both males and females.
Recently, oral RSV (22.4 mg  kg
1  day
1) administra-
tion was shown to improve insulin sensitivity and slightly
reduce the body weight in high-calorie diet–fed mice (12).
In addition, RSV (400 mg  kg
1  day
1) has been demon-
strated to diminish high-fat diet–induced obesity and re-
lated insulin resistance via SIRT1-mediated deacetylation
of peroxisome proliferator–activated receptor- coactiva-
tor-1 (13). In a more recent report, RSV (0.01–1 mol/l)
enhances insulin sensitivity in C2C12 myotubes by re-
pressing PTP1B in a SIRT1-dependent manner, and RSV
(2.5 mg  kg
1  day
1) is sufﬁcient to attenuate high-fat
diet–induced insulin resistance. The dosages of RSV used
in these in vivo and in vitro studies are much lower than
those in the above-mentioned reports (25). The wide range
of concentrations and doses used to achieve the various
effects reported for RSV (
32–100 mol/l in vitro and

100–1,500 mg/kg in animals) raises many questions
about the concentrations that are achieved or achievable
in vivo (34). The dose of RSV applied in our study was 1 mg
 kg
1  day
1 (in vivo) and 0.1–0.3 mol/l (in vitro), which
can possibly be achieved by oral red wine consumption.
Recently, it was demonstrated that a 2-week consumption of
red wine (360 ml/day) substantially attenuates insulin resis-
tance in type 2 diabetic patients (35). The calculated maximal
concentration of RSV (red wine contains 0.1–14.3 mg/l trans-
RSV) in the above case is 
73 g/kg. It is of therapeutic
importance to choose a relatively low dose of RSV for clinical
application, since lower concentrations mean greater biolog-
ical safety and lower pharmaceutical cost.
It has been reported that RSV treatment could reduce
many of the negative consequences under excess caloric
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FIG. 5. In C2C12 myotubes, RSV-induced p38, Erk, Akt, and InsR phosphorylation in a time-dependent manner. A: Equal amounts of proteins were
resolved on 10% SDS-PAGE and blotted with respective p-p38 (thr180/tyr182), p38, p-Erk (thr202/tyr204), Erk, p-Akt (thr308 and ser473), Akt,
p-InsR (tyr1,146), and InsR antibodies. B: The densitometric measurements of protein bands in A. Representative images and densitometries
from three independent experiments are shown (*P < 0.05; **P < 0.01; ***P < 0.001 vs. basal control).
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diet–induced obesity (12,13,25). Nevertheless, our results
demonstrated that RSV diminished HCF diet–induced in-
sulin resistance in the absence of the changes in body
weight and caloric intake. Accordingly, under euglycemic-
hyperinsulinemic conditions, insulin-stimulated glucose
uptake on epididymal fat pad exhibited no signiﬁcant
difference among the groups, indicating that visceral fat
tissue may not be the major target for RSV action on
insulin resistance in our model.
The present study was focused on the RSV effect on
HCF diet–fed insulin-resistant rats but not on healthy rats.
However, our previous study (14) did show that normal
Sprague-Dawley rats treated with RSV acutely (0.5 mg/kg,
90 min after RSV feeding) alone signiﬁcantly decreased
blood glucose as well as improved insulin sensitivity
during a glucose tolerance test. It has been reported that
400 mg  kg
1  day
1 RSV for 15 weeks signiﬁcantly
increases the animal’s capability to resist muscle fatigue
and concomitantly increased mitochondria activity in ab-
sence of body weight change (13).
In conclusion, RSV, an ER agonist, via ER- activation,
is critical for its effects on enhancing muscular glucose
uptake via both insulin-dependent and -independent path-
ways. The dual effects of RSV on glucose metabolism are
of clinical importance to treat subjects with type 2 diabe-
tes, especially in those with end-stage diabetes. The met-
abolic effects of RSV-enhanced ER activation might also
provide a valuable new strategy for treating menopausal
women with type 2 diabetes.
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